Chemoinformaics analysis of 2-methyl-n-[1-(3-phenylprop-2-enoyl)pyrrolidin-2-yl]butanamide
Molecular Weight | 300.402 | nRot | 5 |
Heavy Atom Molecular Weight | 276.21 | nRig | 14 |
Exact Molecular Weight | 300.184 | nRing | 2 |
Solubility: LogS | -2.986 | nHRing | 1 |
Solubility: LogP | 2.692 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 46 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 1 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 18 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 2 | No. of Arom Atom | 6 |
No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
nHA | 2 | APOL | 49.867 |
nHD | 1 | BPOL | 28.093 |
QED | 0.85 |
Synth | 3.045 |
Natural Product Likeliness | 0.393 |
NR-PPAR-gamma | 0.031 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.907 |
Pgp-sub | 0.004 |
HIA | 0.007 |
CACO-2 | -4.613 |
MDCK | 0.0000412 |
BBB | 0.554 |
PPB | 0.94075 |
VDSS | 0.822 |
FU | 0.0496204 |
CYP1A2-inh | 0.317 |
CYP1A2-sub | 0.273 |
CYP2c19-inh | 0.71 |
CYP2c19-sub | 0.804 |
CYP2c9-inh | 0.352 |
CYP2c9-sub | 0.242 |
CYP2d6-inh | 0.017 |
CYP2d6-sub | 0.23 |
CYP3a4-inh | 0.11 |
CYP3a4-sub | 0.268 |
CL | 2.928 |
T12 | 0.745 |
hERG | 0.075 |
Ames | 0.015 |
ROA | 0.662 |
SkinSen | 0.781 |
Carcinogencity | 0.214 |
EI | 0.066 |
Respiratory | 0.736 |
NR-Aromatase | 0.011 |
Antiviral | Yes |
Prediction | 0.736561 |